nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Niclosamide—Clonazepam—epilepsy syndrome	0.28	1	CrCrCtD
Tolcapone—Parkinson's disease—Clonazepam—epilepsy syndrome	0.191	0.554	CpDpCtD
Tolcapone—Parkinson's disease—Gabapentin—epilepsy syndrome	0.154	0.446	CpDpCtD
Tolcapone—CYP2C9—Trimethadione—epilepsy syndrome	0.0304	0.17	CbGbCtD
Tolcapone—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0285	0.16	CbGbCtD
Tolcapone—CYP2C9—Carbamazepine—epilepsy syndrome	0.0205	0.115	CbGbCtD
Tolcapone—CYP2C9—Primidone—epilepsy syndrome	0.0191	0.107	CbGbCtD
Tolcapone—CYP2C9—Phenytoin—epilepsy syndrome	0.0184	0.103	CbGbCtD
Tolcapone—CYP2C9—Propofol—epilepsy syndrome	0.0172	0.0962	CbGbCtD
Tolcapone—CYP2C9—Phenobarbital—epilepsy syndrome	0.0164	0.0919	CbGbCtD
Tolcapone—CYP2C9—Diazepam—epilepsy syndrome	0.0155	0.0872	CbGbCtD
Tolcapone—CYP2C9—Valproic Acid—epilepsy syndrome	0.0122	0.0687	CbGbCtD
Tolcapone—COMT—telencephalic ventricle—epilepsy syndrome	0.00257	0.278	CbGeAlD
Tolcapone—COMT—ganglion—epilepsy syndrome	0.0016	0.173	CbGeAlD
Tolcapone—COMT—brainstem—epilepsy syndrome	0.000696	0.0753	CbGeAlD
Tolcapone—COMT—forebrain—epilepsy syndrome	0.000672	0.0727	CbGeAlD
Tolcapone—COMT—telencephalon—epilepsy syndrome	0.000618	0.0668	CbGeAlD
Tolcapone—COMT—medulla oblongata—epilepsy syndrome	0.000485	0.0525	CbGeAlD
Tolcapone—COMT—midbrain—epilepsy syndrome	0.000444	0.048	CbGeAlD
Tolcapone—COMT—spinal cord—epilepsy syndrome	0.000433	0.0468	CbGeAlD
Tolcapone—COMT—head—epilepsy syndrome	0.000385	0.0416	CbGeAlD
Tolcapone—COMT—nervous system—epilepsy syndrome	0.000365	0.0395	CbGeAlD
Tolcapone—COMT—central nervous system—epilepsy syndrome	0.000351	0.038	CbGeAlD
Tolcapone—COMT—cerebellum—epilepsy syndrome	0.000343	0.0371	CbGeAlD
Tolcapone—COMT—brain—epilepsy syndrome	0.000279	0.0302	CbGeAlD
Tolcapone—COMT—Neuronal System—HCN1—epilepsy syndrome	0.000238	0.00767	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNQ2—epilepsy syndrome	0.000224	0.00721	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNQ3—epilepsy syndrome	0.000224	0.00721	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNA2—epilepsy syndrome	0.000224	0.00721	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—NSF—epilepsy syndrome	0.000221	0.00713	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SYN1—epilepsy syndrome	0.000221	0.00713	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—STXBP1—epilepsy syndrome	0.000215	0.00693	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNB1—epilepsy syndrome	0.000212	0.00683	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CACNB4—epilepsy syndrome	0.000212	0.00683	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CACNA2D2—epilepsy syndrome	0.000212	0.00683	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SLC1A1—epilepsy syndrome	0.00021	0.00676	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GABRG2—epilepsy syndrome	0.000203	0.00652	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNH1—epilepsy syndrome	0.000203	0.00652	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GABRA5—epilepsy syndrome	0.0002	0.00645	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—KCNJ10—epilepsy syndrome	0.0002	0.00645	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIA4—epilepsy syndrome	0.0002	0.00645	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—ABAT—epilepsy syndrome	0.0002	0.00645	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CACNA1A—epilepsy syndrome	0.0002	0.00645	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP2C19—epilepsy syndrome	0.000195	0.00629	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—ARHGEF9—epilepsy syndrome	0.000192	0.00618	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GABRA1—epilepsy syndrome	0.000192	0.00618	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SLC17A7—epilepsy syndrome	0.000192	0.00618	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GABRB3—epilepsy syndrome	0.000192	0.00618	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GLUL—epilepsy syndrome	0.000188	0.00606	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000188	0.00605	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIA2—epilepsy syndrome	0.000185	0.00595	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SLC1A2—epilepsy syndrome	0.000179	0.00575	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIK1—epilepsy syndrome	0.000179	0.00575	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA7—epilepsy syndrome	0.000179	0.00575	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP2D6—epilepsy syndrome	0.000175	0.00564	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GABRB2—epilepsy syndrome	0.00017	0.00548	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—NSF—epilepsy syndrome	0.00017	0.00546	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SYN1—epilepsy syndrome	0.00017	0.00546	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000169	0.00542	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.000168	0.0054	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—STXBP1—epilepsy syndrome	0.000165	0.00531	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000162	0.00521	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SLC1A1—epilepsy syndrome	0.000161	0.00518	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000154	0.00496	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIA4—epilepsy syndrome	0.000153	0.00494	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—ABAT—epilepsy syndrome	0.000153	0.00494	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CACNA1A—epilepsy syndrome	0.000153	0.00494	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GABRA5—epilepsy syndrome	0.000153	0.00494	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNJ10—epilepsy syndrome	0.000153	0.00494	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000152	0.00489	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000152	0.00489	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GABRB3—epilepsy syndrome	0.000147	0.00474	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—ARHGEF9—epilepsy syndrome	0.000147	0.00474	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GABRA1—epilepsy syndrome	0.000147	0.00474	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SLC17A7—epilepsy syndrome	0.000147	0.00474	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000146	0.00468	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GLUL—epilepsy syndrome	0.000144	0.00464	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIA2—epilepsy syndrome	0.000142	0.00456	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.000139	0.00447	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SLC1A2—epilepsy syndrome	0.000137	0.0044	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNA7—epilepsy syndrome	0.000137	0.0044	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIK1—epilepsy syndrome	0.000137	0.0044	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP2C19—epilepsy syndrome	0.000136	0.00438	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000135	0.00435	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000135	0.00435	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000135	0.00435	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP11A1—epilepsy syndrome	0.000135	0.00435	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000134	0.00432	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.000134	0.00432	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000133	0.00429	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GABRB2—epilepsy syndrome	0.00013	0.0042	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GAD2—epilepsy syndrome	0.000129	0.00414	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.000128	0.00412	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP2D6—epilepsy syndrome	0.000122	0.00393	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNMA1—epilepsy syndrome	0.000122	0.00392	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.00012	0.00387	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000116	0.00374	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNJ11—epilepsy syndrome	0.000116	0.00374	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIK2—epilepsy syndrome	0.000116	0.00374	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SLC1A3—epilepsy syndrome	0.000116	0.00374	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GAD1—epilepsy syndrome	0.000112	0.00359	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GABBR1—epilepsy syndrome	0.000106	0.00342	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000104	0.00336	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIA1—epilepsy syndrome	0.000104	0.00334	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SLC6A1—epilepsy syndrome	0.000104	0.00334	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIN2A—epilepsy syndrome	0.000104	0.00334	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000103	0.0033	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.0001	0.00322	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNB2—epilepsy syndrome	9.82e-05	0.00316	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	9.78e-05	0.00315	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	9.68e-05	0.00311	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	9.39e-05	0.00302	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CA13—epilepsy syndrome	9.31e-05	0.003	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNA4—epilepsy syndrome	8.91e-05	0.00287	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	8.59e-05	0.00276	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	8.18e-05	0.00263	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	8.17e-05	0.00263	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	8.11e-05	0.00261	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	8.06e-05	0.00259	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	8e-05	0.00258	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	7.96e-05	0.00256	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—BCHE—epilepsy syndrome	7.86e-05	0.00253	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—DLG4—epilepsy syndrome	7.67e-05	0.00247	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIN2B—epilepsy syndrome	7.49e-05	0.00241	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—PLCB1—epilepsy syndrome	7.41e-05	0.00239	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	7.28e-05	0.00234	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	7.18e-05	0.00231	CbGpPWpGaD
Tolcapone—COMT—Metabolism—FAR1—epilepsy syndrome	7.05e-05	0.00227	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GLUD1—epilepsy syndrome	7.05e-05	0.00227	CbGpPWpGaD
Tolcapone—COMT—Metabolism—L2HGDH—epilepsy syndrome	7.05e-05	0.00227	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CERS1—epilepsy syndrome	7.05e-05	0.00227	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PDXK—epilepsy syndrome	7.05e-05	0.00227	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ADK—epilepsy syndrome	7.05e-05	0.00227	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	6.58e-05	0.00212	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	6.54e-05	0.0021	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PNPO—epilepsy syndrome	6.45e-05	0.00208	CbGpPWpGaD
Tolcapone—COMT—Metabolism—EPM2A—epilepsy syndrome	6.45e-05	0.00208	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NHLRC1—epilepsy syndrome	6.45e-05	0.00208	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GAMT—epilepsy syndrome	6.45e-05	0.00208	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CA4—epilepsy syndrome	6e-05	0.00193	CbGpPWpGaD
Tolcapone—COMT—Metabolism—QDPR—epilepsy syndrome	6e-05	0.00193	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—POMC—epilepsy syndrome	5.98e-05	0.00192	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	5.9e-05	0.0019	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	5.82e-05	0.00187	CbGpPWpGaD
Tolcapone—COMT—Metabolism—COX3—epilepsy syndrome	5.64e-05	0.00181	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—GPX1—epilepsy syndrome	5.59e-05	0.0018	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CACNA2D2—epilepsy syndrome	5.35e-05	0.00172	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PFKL—epilepsy syndrome	5.35e-05	0.00172	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLCO1A2—epilepsy syndrome	5.35e-05	0.00172	CbGpPWpGaD
Tolcapone—COMT—Metabolism—KCNB1—epilepsy syndrome	5.35e-05	0.00172	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC6A8—epilepsy syndrome	5.35e-05	0.00172	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NEU1—epilepsy syndrome	4.89e-05	0.00157	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ATIC—epilepsy syndrome	4.89e-05	0.00157	CbGpPWpGaD
Tolcapone—COMT—Metabolism—UPB1—epilepsy syndrome	4.89e-05	0.00157	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HSD17B4—epilepsy syndrome	4.71e-05	0.00151	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPP1R3C—epilepsy syndrome	4.55e-05	0.00146	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GBE1—epilepsy syndrome	4.55e-05	0.00146	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—PRKCB—epilepsy syndrome	4.46e-05	0.00143	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ASAH1—epilepsy syndrome	4.27e-05	0.00138	CbGpPWpGaD
Tolcapone—COMT—Metabolism—STXBP1—epilepsy syndrome	4.16e-05	0.00134	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	4.07e-05	0.00131	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	4.07e-05	0.00131	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NT5E—epilepsy syndrome	4.05e-05	0.0013	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALAD—epilepsy syndrome	4.05e-05	0.0013	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALDH7A1—epilepsy syndrome	3.86e-05	0.00124	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CACNA1A—epilepsy syndrome	3.86e-05	0.00124	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ST3GAL3—epilepsy syndrome	3.78e-05	0.00122	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ADSL—epilepsy syndrome	3.71e-05	0.00119	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GLUL—epilepsy syndrome	3.63e-05	0.00117	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CACNA1D—epilepsy syndrome	3.57e-05	0.00115	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.56e-05	0.00115	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2C19—epilepsy syndrome	3.49e-05	0.00112	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP11A1—epilepsy syndrome	3.47e-05	0.00112	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.45e-05	0.00111	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.42e-05	0.0011	CbGpPWpGaD
Tolcapone—COMT—Metabolism—TXNRD1—epilepsy syndrome	3.34e-05	0.00107	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	3.29e-05	0.00106	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AQP1—epilepsy syndrome	3.24e-05	0.00104	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	3.13e-05	0.00101	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.09e-05	0.000995	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	3.08e-05	0.000992	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CHRM3—epilepsy syndrome	2.93e-05	0.000943	CbGpPWpGaD
Tolcapone—COMT—Metabolism—KCNJ11—epilepsy syndrome	2.93e-05	0.000943	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.89e-05	0.00093	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.82e-05	0.000907	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.71e-05	0.000873	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.46e-05	0.000793	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CA13—epilepsy syndrome	2.39e-05	0.000769	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCG2—epilepsy syndrome	2.39e-05	0.000768	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2C19—epilepsy syndrome	2.33e-05	0.000749	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP11A1—epilepsy syndrome	2.31e-05	0.000744	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2D6—epilepsy syndrome	2.09e-05	0.000672	CbGpPWpGaD
Tolcapone—Headache—Vigabatrin—epilepsy syndrome	2.06e-05	0.000132	CcSEcCtD
Tolcapone—Hypertension—Pregabalin—epilepsy syndrome	2.06e-05	0.000131	CcSEcCtD
Tolcapone—Vomiting—Diazepam—epilepsy syndrome	2.06e-05	0.000131	CcSEcCtD
Tolcapone—Anorexia—Valproic Acid—epilepsy syndrome	2.05e-05	0.000131	CcSEcCtD
Tolcapone—Tremor—Gabapentin—epilepsy syndrome	2.05e-05	0.000131	CcSEcCtD
Tolcapone—Rash—Diazepam—epilepsy syndrome	2.04e-05	0.00013	CcSEcCtD
Tolcapone—Dermatitis—Diazepam—epilepsy syndrome	2.04e-05	0.00013	CcSEcCtD
Tolcapone—Arthralgia—Pregabalin—epilepsy syndrome	2.03e-05	0.00013	CcSEcCtD
Tolcapone—Myalgia—Pregabalin—epilepsy syndrome	2.03e-05	0.00013	CcSEcCtD
Tolcapone—Chest pain—Pregabalin—epilepsy syndrome	2.03e-05	0.00013	CcSEcCtD
Tolcapone—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.03e-05	0.00013	CcSEcCtD
Tolcapone—Dizziness—Zonisamide—epilepsy syndrome	2.03e-05	0.00013	CcSEcCtD
Tolcapone—Headache—Diazepam—epilepsy syndrome	2.03e-05	0.00013	CcSEcCtD
Tolcapone—Anxiety—Pregabalin—epilepsy syndrome	2.02e-05	0.000129	CcSEcCtD
Tolcapone—Diarrhoea—Clonazepam—epilepsy syndrome	2.02e-05	0.000129	CcSEcCtD
Tolcapone—Anaemia—Gabapentin—epilepsy syndrome	2.02e-05	0.000129	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.02e-05	0.000129	CcSEcCtD
Tolcapone—Hypotension—Valproic Acid—epilepsy syndrome	2.01e-05	0.000128	CcSEcCtD
Tolcapone—Asthenia—Carbamazepine—epilepsy syndrome	2.01e-05	0.000128	CcSEcCtD
Tolcapone—Agitation—Gabapentin—epilepsy syndrome	2.01e-05	0.000128	CcSEcCtD
Tolcapone—Diarrhoea—Phenytoin—epilepsy syndrome	2.01e-05	0.000128	CcSEcCtD
Tolcapone—Discomfort—Pregabalin—epilepsy syndrome	2.01e-05	0.000128	CcSEcCtD
Tolcapone—Nausea—Fosphenytoin—epilepsy syndrome	2.01e-05	0.000128	CcSEcCtD
Tolcapone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2e-05	0.000128	CcSEcCtD
Tolcapone—Erythema multiforme—Topiramate—epilepsy syndrome	2e-05	0.000128	CcSEcCtD
Tolcapone—Hypersensitivity—Lamotrigine—epilepsy syndrome	2e-05	0.000127	CcSEcCtD
Tolcapone—Vomiting—Felbamate—epilepsy syndrome	1.99e-05	0.000127	CcSEcCtD
Tolcapone—COMT—Metabolism—ADRA2A—epilepsy syndrome	1.99e-05	0.000639	CbGpPWpGaD
Tolcapone—Dry mouth—Pregabalin—epilepsy syndrome	1.99e-05	0.000127	CcSEcCtD
Tolcapone—Pruritus—Carbamazepine—epilepsy syndrome	1.98e-05	0.000127	CcSEcCtD
Tolcapone—COMT—Metabolism—BCHE—epilepsy syndrome	1.98e-05	0.000637	CbGpPWpGaD
Tolcapone—Rash—Felbamate—epilepsy syndrome	1.98e-05	0.000126	CcSEcCtD
Tolcapone—Dermatitis—Felbamate—epilepsy syndrome	1.98e-05	0.000126	CcSEcCtD
Tolcapone—Malaise—Gabapentin—epilepsy syndrome	1.97e-05	0.000126	CcSEcCtD
Tolcapone—Tinnitus—Topiramate—epilepsy syndrome	1.97e-05	0.000126	CcSEcCtD
Tolcapone—Vertigo—Gabapentin—epilepsy syndrome	1.97e-05	0.000125	CcSEcCtD
Tolcapone—Headache—Felbamate—epilepsy syndrome	1.96e-05	0.000125	CcSEcCtD
Tolcapone—Confusional state—Pregabalin—epilepsy syndrome	1.96e-05	0.000125	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.96e-05	0.000125	CcSEcCtD
Tolcapone—Syncope—Gabapentin—epilepsy syndrome	1.96e-05	0.000125	CcSEcCtD
Tolcapone—Dizziness—Clonazepam—epilepsy syndrome	1.96e-05	0.000125	CcSEcCtD
Tolcapone—Nausea—Vigabatrin—epilepsy syndrome	1.95e-05	0.000125	CcSEcCtD
Tolcapone—Vomiting—Zonisamide—epilepsy syndrome	1.95e-05	0.000125	CcSEcCtD
Tolcapone—Oedema—Pregabalin—epilepsy syndrome	1.95e-05	0.000124	CcSEcCtD
Tolcapone—Asthenia—Lamotrigine—epilepsy syndrome	1.94e-05	0.000124	CcSEcCtD
Tolcapone—Dizziness—Phenytoin—epilepsy syndrome	1.94e-05	0.000124	CcSEcCtD
Tolcapone—Rash—Zonisamide—epilepsy syndrome	1.94e-05	0.000123	CcSEcCtD
Tolcapone—Infection—Pregabalin—epilepsy syndrome	1.93e-05	0.000123	CcSEcCtD
Tolcapone—Paraesthesia—Valproic Acid—epilepsy syndrome	1.93e-05	0.000123	CcSEcCtD
Tolcapone—Palpitations—Gabapentin—epilepsy syndrome	1.93e-05	0.000123	CcSEcCtD
Tolcapone—Dermatitis—Zonisamide—epilepsy syndrome	1.93e-05	0.000123	CcSEcCtD
Tolcapone—Dizziness—Oxcarbazepine—epilepsy syndrome	1.93e-05	0.000123	CcSEcCtD
Tolcapone—Nausea—Diazepam—epilepsy syndrome	1.92e-05	0.000123	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.92e-05	0.000619	CbGpPWpGaD
Tolcapone—Loss of consciousness—Gabapentin—epilepsy syndrome	1.92e-05	0.000123	CcSEcCtD
Tolcapone—Headache—Zonisamide—epilepsy syndrome	1.92e-05	0.000123	CcSEcCtD
Tolcapone—Dyspnoea—Valproic Acid—epilepsy syndrome	1.92e-05	0.000123	CcSEcCtD
Tolcapone—Diarrhoea—Carbamazepine—epilepsy syndrome	1.92e-05	0.000122	CcSEcCtD
Tolcapone—Angiopathy—Topiramate—epilepsy syndrome	1.92e-05	0.000122	CcSEcCtD
Tolcapone—Pruritus—Lamotrigine—epilepsy syndrome	1.92e-05	0.000122	CcSEcCtD
Tolcapone—Shock—Pregabalin—epilepsy syndrome	1.92e-05	0.000122	CcSEcCtD
Tolcapone—Somnolence—Valproic Acid—epilepsy syndrome	1.91e-05	0.000122	CcSEcCtD
Tolcapone—Nervous system disorder—Pregabalin—epilepsy syndrome	1.91e-05	0.000122	CcSEcCtD
Tolcapone—Cough—Gabapentin—epilepsy syndrome	1.91e-05	0.000122	CcSEcCtD
Tolcapone—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.91e-05	0.000122	CcSEcCtD
Tolcapone—Mediastinal disorder—Topiramate—epilepsy syndrome	1.91e-05	0.000122	CcSEcCtD
Tolcapone—Tachycardia—Pregabalin—epilepsy syndrome	1.9e-05	0.000121	CcSEcCtD
Tolcapone—Chills—Topiramate—epilepsy syndrome	1.9e-05	0.000121	CcSEcCtD
Tolcapone—Dyspepsia—Valproic Acid—epilepsy syndrome	1.9e-05	0.000121	CcSEcCtD
Tolcapone—Skin disorder—Pregabalin—epilepsy syndrome	1.89e-05	0.000121	CcSEcCtD
Tolcapone—Hypertension—Gabapentin—epilepsy syndrome	1.89e-05	0.000121	CcSEcCtD
Tolcapone—COMT—Metabolism—SLC2A1—epilepsy syndrome	1.89e-05	0.000607	CbGpPWpGaD
Tolcapone—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.88e-05	0.00012	CcSEcCtD
Tolcapone—Vomiting—Clonazepam—epilepsy syndrome	1.88e-05	0.00012	CcSEcCtD
Tolcapone—Decreased appetite—Valproic Acid—epilepsy syndrome	1.87e-05	0.000119	CcSEcCtD
Tolcapone—Alopecia—Topiramate—epilepsy syndrome	1.87e-05	0.000119	CcSEcCtD
Tolcapone—Vomiting—Phenytoin—epilepsy syndrome	1.87e-05	0.000119	CcSEcCtD
Tolcapone—COMT—Metabolism—PLCB1—epilepsy syndrome	1.87e-05	0.000601	CbGpPWpGaD
Tolcapone—Rash—Clonazepam—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—Dermatitis—Clonazepam—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—Myalgia—Gabapentin—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—Chest pain—Gabapentin—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—Arthralgia—Gabapentin—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—Nausea—Felbamate—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—COMT—Metabolism—TH—epilepsy syndrome	1.86e-05	0.000599	CbGpPWpGaD
Tolcapone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—Vomiting—Oxcarbazepine—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—Fatigue—Valproic Acid—epilepsy syndrome	1.86e-05	0.000119	CcSEcCtD
Tolcapone—Anxiety—Gabapentin—epilepsy syndrome	1.86e-05	0.000118	CcSEcCtD
Tolcapone—Anorexia—Pregabalin—epilepsy syndrome	1.86e-05	0.000118	CcSEcCtD
Tolcapone—Dizziness—Carbamazepine—epilepsy syndrome	1.85e-05	0.000118	CcSEcCtD
Tolcapone—Diarrhoea—Lamotrigine—epilepsy syndrome	1.85e-05	0.000118	CcSEcCtD
Tolcapone—Headache—Clonazepam—epilepsy syndrome	1.85e-05	0.000118	CcSEcCtD
Tolcapone—Rash—Phenytoin—epilepsy syndrome	1.85e-05	0.000118	CcSEcCtD
Tolcapone—Mental disorder—Topiramate—epilepsy syndrome	1.85e-05	0.000118	CcSEcCtD
Tolcapone—Dermatitis—Phenytoin—epilepsy syndrome	1.85e-05	0.000118	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.85e-05	0.000118	CcSEcCtD
Tolcapone—Rash—Oxcarbazepine—epilepsy syndrome	1.84e-05	0.000118	CcSEcCtD
Tolcapone—Pain—Valproic Acid—epilepsy syndrome	1.84e-05	0.000118	CcSEcCtD
Tolcapone—Constipation—Valproic Acid—epilepsy syndrome	1.84e-05	0.000118	CcSEcCtD
Tolcapone—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.84e-05	0.000117	CcSEcCtD
Tolcapone—Headache—Phenytoin—epilepsy syndrome	1.84e-05	0.000117	CcSEcCtD
Tolcapone—Discomfort—Gabapentin—epilepsy syndrome	1.84e-05	0.000117	CcSEcCtD
Tolcapone—Headache—Oxcarbazepine—epilepsy syndrome	1.83e-05	0.000117	CcSEcCtD
Tolcapone—Nausea—Zonisamide—epilepsy syndrome	1.82e-05	0.000116	CcSEcCtD
Tolcapone—Dry mouth—Gabapentin—epilepsy syndrome	1.82e-05	0.000116	CcSEcCtD
Tolcapone—Hypotension—Pregabalin—epilepsy syndrome	1.82e-05	0.000116	CcSEcCtD
Tolcapone—Flatulence—Topiramate—epilepsy syndrome	1.81e-05	0.000116	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.81e-05	0.000583	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.81e-05	0.000583	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.81e-05	0.000583	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.81e-05	0.000583	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.81e-05	0.000583	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.81e-05	0.000583	CbGpPWpGaD
Tolcapone—Tension—Topiramate—epilepsy syndrome	1.81e-05	0.000115	CcSEcCtD
Tolcapone—Dysgeusia—Topiramate—epilepsy syndrome	1.8e-05	0.000115	CcSEcCtD
Tolcapone—Confusional state—Gabapentin—epilepsy syndrome	1.8e-05	0.000115	CcSEcCtD
Tolcapone—Dizziness—Lamotrigine—epilepsy syndrome	1.79e-05	0.000114	CcSEcCtD
Tolcapone—Nervousness—Topiramate—epilepsy syndrome	1.79e-05	0.000114	CcSEcCtD
Tolcapone—Oedema—Gabapentin—epilepsy syndrome	1.79e-05	0.000114	CcSEcCtD
Tolcapone—Vomiting—Carbamazepine—epilepsy syndrome	1.78e-05	0.000114	CcSEcCtD
Tolcapone—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.77e-05	0.000113	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.77e-05	0.000113	CcSEcCtD
Tolcapone—Infection—Gabapentin—epilepsy syndrome	1.77e-05	0.000113	CcSEcCtD
Tolcapone—Muscle spasms—Topiramate—epilepsy syndrome	1.77e-05	0.000113	CcSEcCtD
Tolcapone—Rash—Carbamazepine—epilepsy syndrome	1.77e-05	0.000113	CcSEcCtD
Tolcapone—Dermatitis—Carbamazepine—epilepsy syndrome	1.77e-05	0.000113	CcSEcCtD
Tolcapone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.76e-05	0.000112	CcSEcCtD
Tolcapone—Nausea—Clonazepam—epilepsy syndrome	1.76e-05	0.000112	CcSEcCtD
Tolcapone—Headache—Carbamazepine—epilepsy syndrome	1.76e-05	0.000112	CcSEcCtD
Tolcapone—Shock—Gabapentin—epilepsy syndrome	1.76e-05	0.000112	CcSEcCtD
Tolcapone—Nervous system disorder—Gabapentin—epilepsy syndrome	1.75e-05	0.000112	CcSEcCtD
Tolcapone—Paraesthesia—Pregabalin—epilepsy syndrome	1.75e-05	0.000112	CcSEcCtD
Tolcapone—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.75e-05	0.000112	CcSEcCtD
Tolcapone—Nausea—Phenytoin—epilepsy syndrome	1.75e-05	0.000111	CcSEcCtD
Tolcapone—Tachycardia—Gabapentin—epilepsy syndrome	1.74e-05	0.000111	CcSEcCtD
Tolcapone—Dyspnoea—Pregabalin—epilepsy syndrome	1.74e-05	0.000111	CcSEcCtD
Tolcapone—Nausea—Oxcarbazepine—epilepsy syndrome	1.74e-05	0.000111	CcSEcCtD
Tolcapone—Vision blurred—Topiramate—epilepsy syndrome	1.73e-05	0.000111	CcSEcCtD
Tolcapone—Skin disorder—Gabapentin—epilepsy syndrome	1.73e-05	0.000111	CcSEcCtD
Tolcapone—Somnolence—Pregabalin—epilepsy syndrome	1.73e-05	0.00011	CcSEcCtD
Tolcapone—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.73e-05	0.00011	CcSEcCtD
Tolcapone—Tremor—Topiramate—epilepsy syndrome	1.72e-05	0.00011	CcSEcCtD
Tolcapone—Vomiting—Lamotrigine—epilepsy syndrome	1.72e-05	0.00011	CcSEcCtD
Tolcapone—Urticaria—Valproic Acid—epilepsy syndrome	1.71e-05	0.000109	CcSEcCtD
Tolcapone—Rash—Lamotrigine—epilepsy syndrome	1.71e-05	0.000109	CcSEcCtD
Tolcapone—Ill-defined disorder—Topiramate—epilepsy syndrome	1.71e-05	0.000109	CcSEcCtD
Tolcapone—Dermatitis—Lamotrigine—epilepsy syndrome	1.71e-05	0.000109	CcSEcCtD
Tolcapone—Abdominal pain—Valproic Acid—epilepsy syndrome	1.7e-05	0.000109	CcSEcCtD
Tolcapone—Body temperature increased—Valproic Acid—epilepsy syndrome	1.7e-05	0.000109	CcSEcCtD
Tolcapone—Anorexia—Gabapentin—epilepsy syndrome	1.7e-05	0.000109	CcSEcCtD
Tolcapone—Anaemia—Topiramate—epilepsy syndrome	1.7e-05	0.000109	CcSEcCtD
Tolcapone—Headache—Lamotrigine—epilepsy syndrome	1.7e-05	0.000108	CcSEcCtD
Tolcapone—Decreased appetite—Pregabalin—epilepsy syndrome	1.69e-05	0.000108	CcSEcCtD
Tolcapone—Agitation—Topiramate—epilepsy syndrome	1.69e-05	0.000108	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.68e-05	0.000107	CcSEcCtD
Tolcapone—Fatigue—Pregabalin—epilepsy syndrome	1.68e-05	0.000107	CcSEcCtD
Tolcapone—Hypotension—Gabapentin—epilepsy syndrome	1.67e-05	0.000106	CcSEcCtD
Tolcapone—Nausea—Carbamazepine—epilepsy syndrome	1.67e-05	0.000106	CcSEcCtD
Tolcapone—Pain—Pregabalin—epilepsy syndrome	1.67e-05	0.000106	CcSEcCtD
Tolcapone—Constipation—Pregabalin—epilepsy syndrome	1.67e-05	0.000106	CcSEcCtD
Tolcapone—Malaise—Topiramate—epilepsy syndrome	1.66e-05	0.000106	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.66e-05	0.000533	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.66e-05	0.000533	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.66e-05	0.000533	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.66e-05	0.000533	CbGpPWpGaD
Tolcapone—Vertigo—Topiramate—epilepsy syndrome	1.65e-05	0.000106	CcSEcCtD
Tolcapone—Syncope—Topiramate—epilepsy syndrome	1.65e-05	0.000105	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.63e-05	0.000104	CcSEcCtD
Tolcapone—Palpitations—Topiramate—epilepsy syndrome	1.63e-05	0.000104	CcSEcCtD
Tolcapone—Loss of consciousness—Topiramate—epilepsy syndrome	1.62e-05	0.000103	CcSEcCtD
Tolcapone—Nausea—Lamotrigine—epilepsy syndrome	1.61e-05	0.000103	CcSEcCtD
Tolcapone—Cough—Topiramate—epilepsy syndrome	1.61e-05	0.000103	CcSEcCtD
Tolcapone—Feeling abnormal—Pregabalin—epilepsy syndrome	1.6e-05	0.000102	CcSEcCtD
Tolcapone—Paraesthesia—Gabapentin—epilepsy syndrome	1.6e-05	0.000102	CcSEcCtD
Tolcapone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.59e-05	0.000102	CcSEcCtD
Tolcapone—Dyspnoea—Gabapentin—epilepsy syndrome	1.59e-05	0.000102	CcSEcCtD
Tolcapone—Hypertension—Topiramate—epilepsy syndrome	1.59e-05	0.000101	CcSEcCtD
Tolcapone—Somnolence—Gabapentin—epilepsy syndrome	1.59e-05	0.000101	CcSEcCtD
Tolcapone—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.59e-05	0.000101	CcSEcCtD
Tolcapone—Dyspepsia—Gabapentin—epilepsy syndrome	1.57e-05	0.0001	CcSEcCtD
Tolcapone—Chest pain—Topiramate—epilepsy syndrome	1.57e-05	0.0001	CcSEcCtD
Tolcapone—Arthralgia—Topiramate—epilepsy syndrome	1.57e-05	0.0001	CcSEcCtD
Tolcapone—Myalgia—Topiramate—epilepsy syndrome	1.57e-05	0.0001	CcSEcCtD
Tolcapone—Anxiety—Topiramate—epilepsy syndrome	1.56e-05	9.97e-05	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.56e-05	9.93e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—HMOX1—epilepsy syndrome	1.55e-05	0.0005	CbGpPWpGaD
Tolcapone—Decreased appetite—Gabapentin—epilepsy syndrome	1.55e-05	9.91e-05	CcSEcCtD
Tolcapone—Discomfort—Topiramate—epilepsy syndrome	1.55e-05	9.88e-05	CcSEcCtD
Tolcapone—Urticaria—Pregabalin—epilepsy syndrome	1.55e-05	9.87e-05	CcSEcCtD
Tolcapone—Asthenia—Valproic Acid—epilepsy syndrome	1.55e-05	9.86e-05	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.54e-05	9.84e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.54e-05	0.000496	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.54e-05	0.000496	CbGpPWpGaD
Tolcapone—Fatigue—Gabapentin—epilepsy syndrome	1.54e-05	9.82e-05	CcSEcCtD
Tolcapone—Abdominal pain—Pregabalin—epilepsy syndrome	1.54e-05	9.82e-05	CcSEcCtD
Tolcapone—Body temperature increased—Pregabalin—epilepsy syndrome	1.54e-05	9.82e-05	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.53e-05	0.000494	CbGpPWpGaD
Tolcapone—Dry mouth—Topiramate—epilepsy syndrome	1.53e-05	9.78e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—CAT—epilepsy syndrome	1.53e-05	0.000493	CbGpPWpGaD
Tolcapone—Constipation—Gabapentin—epilepsy syndrome	1.53e-05	9.74e-05	CcSEcCtD
Tolcapone—Pain—Gabapentin—epilepsy syndrome	1.53e-05	9.74e-05	CcSEcCtD
Tolcapone—Pruritus—Valproic Acid—epilepsy syndrome	1.52e-05	9.72e-05	CcSEcCtD
Tolcapone—Confusional state—Topiramate—epilepsy syndrome	1.51e-05	9.67e-05	CcSEcCtD
Tolcapone—Oedema—Topiramate—epilepsy syndrome	1.5e-05	9.59e-05	CcSEcCtD
Tolcapone—Infection—Topiramate—epilepsy syndrome	1.49e-05	9.52e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—ABCB1—epilepsy syndrome	1.49e-05	0.00048	CbGpPWpGaD
Tolcapone—Shock—Topiramate—epilepsy syndrome	1.48e-05	9.43e-05	CcSEcCtD
Tolcapone—Diarrhoea—Valproic Acid—epilepsy syndrome	1.47e-05	9.4e-05	CcSEcCtD
Tolcapone—Nervous system disorder—Topiramate—epilepsy syndrome	1.47e-05	9.4e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Gabapentin—epilepsy syndrome	1.47e-05	9.39e-05	CcSEcCtD
Tolcapone—Thrombocytopenia—Topiramate—epilepsy syndrome	1.47e-05	9.39e-05	CcSEcCtD
Tolcapone—Tachycardia—Topiramate—epilepsy syndrome	1.47e-05	9.36e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.46e-05	9.32e-05	CcSEcCtD
Tolcapone—Skin disorder—Topiramate—epilepsy syndrome	1.46e-05	9.31e-05	CcSEcCtD
Tolcapone—Hyperhidrosis—Topiramate—epilepsy syndrome	1.45e-05	9.27e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.45e-05	0.000466	CbGpPWpGaD
Tolcapone—Hypersensitivity—Pregabalin—epilepsy syndrome	1.43e-05	9.16e-05	CcSEcCtD
Tolcapone—Anorexia—Topiramate—epilepsy syndrome	1.43e-05	9.14e-05	CcSEcCtD
Tolcapone—Dizziness—Valproic Acid—epilepsy syndrome	1.42e-05	9.09e-05	CcSEcCtD
Tolcapone—Urticaria—Gabapentin—epilepsy syndrome	1.42e-05	9.05e-05	CcSEcCtD
Tolcapone—Abdominal pain—Gabapentin—epilepsy syndrome	1.41e-05	9.01e-05	CcSEcCtD
Tolcapone—Body temperature increased—Gabapentin—epilepsy syndrome	1.41e-05	9.01e-05	CcSEcCtD
Tolcapone—Hypotension—Topiramate—epilepsy syndrome	1.4e-05	8.96e-05	CcSEcCtD
Tolcapone—Asthenia—Pregabalin—epilepsy syndrome	1.4e-05	8.92e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—GPX1—epilepsy syndrome	1.39e-05	0.000446	CbGpPWpGaD
Tolcapone—Pruritus—Pregabalin—epilepsy syndrome	1.38e-05	8.79e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.37e-05	0.000442	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.37e-05	0.000442	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.37e-05	0.000442	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.37e-05	0.000442	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.37e-05	0.000442	CbGpPWpGaD
Tolcapone—Vomiting—Valproic Acid—epilepsy syndrome	1.37e-05	8.74e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.37e-05	8.73e-05	CcSEcCtD
Tolcapone—Rash—Valproic Acid—epilepsy syndrome	1.36e-05	8.67e-05	CcSEcCtD
Tolcapone—Dermatitis—Valproic Acid—epilepsy syndrome	1.36e-05	8.66e-05	CcSEcCtD
Tolcapone—Headache—Valproic Acid—epilepsy syndrome	1.35e-05	8.61e-05	CcSEcCtD
Tolcapone—Paraesthesia—Topiramate—epilepsy syndrome	1.35e-05	8.61e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.34e-05	0.000432	CbGpPWpGaD
Tolcapone—Dyspnoea—Topiramate—epilepsy syndrome	1.34e-05	8.55e-05	CcSEcCtD
Tolcapone—Somnolence—Topiramate—epilepsy syndrome	1.34e-05	8.52e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.33e-05	0.000429	CbGpPWpGaD
Tolcapone—Diarrhoea—Pregabalin—epilepsy syndrome	1.33e-05	8.5e-05	CcSEcCtD
Tolcapone—Dyspepsia—Topiramate—epilepsy syndrome	1.32e-05	8.44e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Gabapentin—epilepsy syndrome	1.32e-05	8.4e-05	CcSEcCtD
Tolcapone—Decreased appetite—Topiramate—epilepsy syndrome	1.31e-05	8.33e-05	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.3e-05	8.28e-05	CcSEcCtD
Tolcapone—Fatigue—Topiramate—epilepsy syndrome	1.3e-05	8.27e-05	CcSEcCtD
Tolcapone—Dizziness—Pregabalin—epilepsy syndrome	1.29e-05	8.22e-05	CcSEcCtD
Tolcapone—Pain—Topiramate—epilepsy syndrome	1.28e-05	8.2e-05	CcSEcCtD
Tolcapone—Constipation—Topiramate—epilepsy syndrome	1.28e-05	8.2e-05	CcSEcCtD
Tolcapone—Asthenia—Gabapentin—epilepsy syndrome	1.28e-05	8.18e-05	CcSEcCtD
Tolcapone—Nausea—Valproic Acid—epilepsy syndrome	1.28e-05	8.16e-05	CcSEcCtD
Tolcapone—Pruritus—Gabapentin—epilepsy syndrome	1.26e-05	8.06e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.26e-05	0.000404	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.26e-05	0.000404	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.26e-05	0.000404	CbGpPWpGaD
Tolcapone—Vomiting—Pregabalin—epilepsy syndrome	1.24e-05	7.9e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Topiramate—epilepsy syndrome	1.24e-05	7.9e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.23e-05	7.84e-05	CcSEcCtD
Tolcapone—Rash—Pregabalin—epilepsy syndrome	1.23e-05	7.84e-05	CcSEcCtD
Tolcapone—Dermatitis—Pregabalin—epilepsy syndrome	1.23e-05	7.83e-05	CcSEcCtD
Tolcapone—Diarrhoea—Gabapentin—epilepsy syndrome	1.22e-05	7.8e-05	CcSEcCtD
Tolcapone—Headache—Pregabalin—epilepsy syndrome	1.22e-05	7.78e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—AGT—epilepsy syndrome	1.21e-05	0.000391	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.21e-05	0.000389	CbGpPWpGaD
Tolcapone—Urticaria—Topiramate—epilepsy syndrome	1.19e-05	7.62e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—APOE—epilepsy syndrome	1.19e-05	0.000383	CbGpPWpGaD
Tolcapone—Abdominal pain—Topiramate—epilepsy syndrome	1.19e-05	7.58e-05	CcSEcCtD
Tolcapone—Body temperature increased—Topiramate—epilepsy syndrome	1.19e-05	7.58e-05	CcSEcCtD
Tolcapone—Dizziness—Gabapentin—epilepsy syndrome	1.18e-05	7.54e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.17e-05	0.000376	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.17e-05	0.000376	CbGpPWpGaD
Tolcapone—Nausea—Pregabalin—epilepsy syndrome	1.16e-05	7.38e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.14e-05	0.000367	CbGpPWpGaD
Tolcapone—Vomiting—Gabapentin—epilepsy syndrome	1.14e-05	7.25e-05	CcSEcCtD
Tolcapone—Rash—Gabapentin—epilepsy syndrome	1.13e-05	7.18e-05	CcSEcCtD
Tolcapone—Dermatitis—Gabapentin—epilepsy syndrome	1.12e-05	7.18e-05	CcSEcCtD
Tolcapone—Headache—Gabapentin—epilepsy syndrome	1.12e-05	7.14e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Topiramate—epilepsy syndrome	1.11e-05	7.06e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.1e-05	0.000353	CbGpPWpGaD
Tolcapone—Asthenia—Topiramate—epilepsy syndrome	1.08e-05	6.88e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.07e-05	0.000344	CbGpPWpGaD
Tolcapone—Pruritus—Topiramate—epilepsy syndrome	1.06e-05	6.78e-05	CcSEcCtD
Tolcapone—Nausea—Gabapentin—epilepsy syndrome	1.06e-05	6.77e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.04e-05	0.000335	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.04e-05	0.000335	CbGpPWpGaD
Tolcapone—Diarrhoea—Topiramate—epilepsy syndrome	1.03e-05	6.56e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—POMC—epilepsy syndrome	1.02e-05	0.000329	CbGpPWpGaD
Tolcapone—Dizziness—Topiramate—epilepsy syndrome	9.93e-06	6.34e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	9.92e-06	0.000319	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	9.92e-06	0.000319	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	9.71e-06	0.000313	CbGpPWpGaD
Tolcapone—Vomiting—Topiramate—epilepsy syndrome	9.55e-06	6.1e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ADSL—epilepsy syndrome	9.51e-06	0.000306	CbGpPWpGaD
Tolcapone—Rash—Topiramate—epilepsy syndrome	9.47e-06	6.04e-05	CcSEcCtD
Tolcapone—Dermatitis—Topiramate—epilepsy syndrome	9.46e-06	6.04e-05	CcSEcCtD
Tolcapone—Headache—Topiramate—epilepsy syndrome	9.41e-06	6.01e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—GLUL—epilepsy syndrome	9.33e-06	0.0003	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALB—epilepsy syndrome	9.32e-06	0.0003	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	9.16e-06	0.000295	CbGpPWpGaD
Tolcapone—Nausea—Topiramate—epilepsy syndrome	8.92e-06	5.69e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	8.56e-06	0.000276	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AQP1—epilepsy syndrome	8.31e-06	0.000268	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS2—epilepsy syndrome	8.16e-06	0.000262	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.99e-06	0.000257	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	7.52e-06	0.000242	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	7.52e-06	0.000242	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7e-06	0.000225	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.86e-06	0.000221	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	6.13e-06	0.000197	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5.97e-06	0.000192	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	5.94e-06	0.000191	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.89e-06	0.00019	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.37e-06	0.000173	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	5.36e-06	0.000172	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	5.1e-06	0.000164	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—BCHE—epilepsy syndrome	5.08e-06	0.000163	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.85e-06	0.000156	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.79e-06	0.000154	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TH—epilepsy syndrome	4.78e-06	0.000154	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.7e-06	0.000151	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—epilepsy syndrome	4.1e-06	0.000132	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.99e-06	0.000128	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.93e-06	0.000127	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.83e-06	0.000123	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.56e-06	0.000114	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.12e-06	0.0001	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.06e-06	9.83e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.62e-06	8.45e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.39e-06	7.7e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.09e-06	6.74e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.05e-06	3.39e-05	CbGpPWpGaD
